Background and aim-Hereditary nonpolyposis colorectal cancer (HNPCC), as its name implies, is associated with few adenomas, and the early evolution of colorectal neoplasia is poorly understood. In this study our aim was to clarify the genetic profiles of benign polyps in subjects with HNPCC using a combined molecular and immunohistochemical approach. Methods-Thirty adenomas and 17 hyperplastic polyps were obtained from 24 aVected HNPCC subjects. DNA was extracted from paraYn embedded tissue by microdissection and analysed for the presence of microsatellite instability (MSI) and mutations in five genes known to be targets in mismatch repair deficiency (TGF RII, IGF2R, BAX, hMSH3, and hMSH6). Serial sections were stained by immunohistochemistry for hMLH1 and hMSH2. (Gut 2000;47:37-42) 
The early evolution of colorectal neoplasia in hereditary non-polyposis colorectal cancer (HNPCC) is poorly understood. While it is sometimes possible to demonstrate residual adenomas adjacent to HNPCC cancers, 1 the use of somatic microsatellite mutations as molecular clocks discloses surprisingly long periods of parallel evolution of adenomas and carcinomas. 2 This suggests that adenomas and carcinomas may not be so much sequentially related but derived from a common precursor lesion of microscopic dimensions. 2 This could explain in part the well authenticated observation of interval cancer in HNPCC in which a patient presents with a cancer soon after a negative colonoscopic examination. 3 Nevertheless, while adenomas are uncommon in HNPCC subjects, a disproportionate number are diagnosed before the age of 50 years, 4 and they are more likely to be large, have a villous morphology, and show high grade dysplasia. 4 These observations have introduced the concept of "aggressive adenoma" in HNPCC 5 in which rapid evolution is driven by the acquisition of genetic instability due in turn to breakdown of the DNA mismatch repair mechanism. 6 DNA mismatch repair deficiency leads to a high level of microsatellite instability (MSI-H) in cancer tissue. It is generally agreed that p53 mutation and 17p and 18q loss of heterozygosity are infrequent in MSI-H cancers, whether HNPCC 7 or sporadic. 8 9 Genes with repetitive tracts in their coding sequences appear to provide an alternative molecular pathway in the evolution of MSI-H colorectal cancers. These include TGF RII, 10 IGF2R, 11 BAX, 12 CDX-2, 13 E2F-4, 14 and caspase 5. 15 However, while microsatellite instability (MSI) may be established at an early stage in adenoma formation, including microscopic aberrant crypt foci, 2 16 17 mutated genes have not been detected at high frequency in adenomas showing MSI. 16 18 19 Mutation of TGF RII has been described as a very early and possibly initiating event 16 whereas others link the TGF RII mutation to the stage of adenoma-carcinoma transition. 18 BAX mutations have also been related to adenoma-carcinoma transition. 19 The extent of genetic instability appears to correlate with the risk of adenoma progression. 20 It has been suggested that the full development of the microsatellite mutator phenotype depends on the recruitment of "secondary" mutators. 21 Among these are hMSH3 and hMSH6, mismatch repair genes that are susceptible to the development of frameshift somatic mutations by virtue of their repetitive encoding sequences. 21 The aim of this study was to stratify a series of adenomas obtained from subjects with a definite diagnosis of HNPCC according to microsatellite status (microsatellite stable (MSS), MSI-low (MSI-L) and MSI-H) and to assess critically the timing of loss of expression of hMLH1 and hMSH2 and recruitment of secondary mutators (MSH3 and MSH6). By correlating these observations with demonstration of mutations in TGF RII, IGF2R, and BAX as well as the classical morphological risk factors for adenoma progression, it should be possible to derive a clearer picture of the molecular steps governing the origin of cancer in HNPCC.
Materials and methods

PATIENTS AND POLYPS
Seventeen hyperplastic polyps and 30 adenomas were obtained from 24 aVected HNPCC subjects as paraYn embedded archival samples. All families met stringent criteria for HNPCC as defined by the International Collaborative Group for HNPCC. 22 Additionally, at least two cancers per family were required to show high levels of DNA MSI. AVected subjects were recruited either on the basis of developing an MSI-H colorectal cancer or a HNPCC associated cancer at less than 50 years of age. Twenty two (73.3%) adenomas were derived from 10 subjects (members of four diVerent families) carrying a germline mutation in hMSH2 or hMLH1. Of the 24 subjects, 10 were male and 14 were female. Some polyps were obtained by surgical resection of synchronous colon cancers and others by endoscopic polypectomy. Between one and 12 polyps were obtained per subject. Serial sections were cut from each paraYn block and the first of these was stained with haematoxylin and eosin for histopathological diagnosis and to serve as a template for microdissection. All patients gave informed consent to the study which was approved by the local institutional review boards. As there is little accumulated experience on immunohistochemistry for hMLH1 and hMSH2, 83 sporadic 8 29 and c-mybT22. 30 The loci D10S197 and D18S58 were analysed only in the case of polyps classified as MSS, MSI-L, or borderline MSI-H with seven loci. The reaction volume for the polymerase chain reaction (PCR) was 10 µl which included 2 µl of the DNA sample, 10 nM of each primer, 2 nM of each deoxynucleotide triphoshate, 1 µl of PCR buVer, 2.5 U of Taq polymerase (Boehringer Mannheim, Mannheim, Germany), and 1 µl of [ 33 P]dATP. PCR was run as previously described. 23 After amplification, PCR products were separated by electrophoresis in 5% denaturing polyacrylamide (19:1) gel and visualised by autoradiography. Tumours showing bandshifts at one or more microsatellite markers were termed MSI (fig 1) . MSI status was subclassified as high (MSI-H) when bandshifts were seen at three markers (including at least one mononucleotide marker) and low (MSI-L) when less instability was detected. Scoring of MSI was undertaken independently by two observers (HI, JY). 32 and the poly(C)8 tract of the hMSH6 gene 32 was investigated by PCR and subsequent polyacrylamide gel electrophoresis. PCR was undertaken as for MSI testing. After amplification, PCR products were separated by electrophoresis in 5% or 8% denaturing polyacrylamide (19:1) gel according to the size of products, and visualized by autoradiography. The presence of bandshifts or an additional band was interpreted as a mutation (fig 1) .
IMMUNOHISTOCHEMISTRY
ParaYn sections (4 µm) were fixed to Superfrost Plus charged slides (Menzelgläser, Braunschweig, Germany) and dried overnight at 37°C. The sections were dewaxed and rehydrated to distilled water through descending graded alcohols. Heat antigen retrieval was performed by autoclaving the sections in 0.001 M EDTA (pH 8.0) for 15 minutes. After cooling, the sections were transferred to Tris buVered saline (TBS), pH 7.4. Endogenous peroxidase activity was quenched by incubating in 1% H 2 O 2 and 0.1% NaN 3 in TBS for 10 minutes. Following thorough washing in TBS, sections were immersed in 4% commercial non-fat skim milk powder in TBS for 15 minutes to inhibit non-specific antibody binding, before being transferred to a humidified chamber and covered with 10% normal (non-immune) goat serum for 30 minutes. Excess serum was decanted from the sections which were then incubated overnight at room temperature with primary monoclonal antibodies to hMLH1 and hMSH2. The monoclonal antibodies G168-15 (anti-hMLH1 diluted 1:75 in TBS) and Ab-2 (anti-hMSH2 diluted 1:120) were obtained from PharMingen (San Diego, California, USA) and Oncogene Research Products (Cambridge, Massachusetts, USA), respectively.
Following the incubations, sections were washed thoroughly in three changes of TBS for five minutes each. Sections were then incubated for 45 minutes with appropriate biotinylated secondary antibodies (Zymed Laboratories, San Francisco, California, USA), and then streptavidin-horseradish peroxidase conjugate (Zymed) for 15 minutes. Antigenic sites were revealed by incubating sections in 0.05% 3,3'-diaminobenzidine in Tris saline with H 2 O 2 as substrate. After washing in gently running tap water, the sections were lightly counterstained with haematoxylin, dehydrated through graded alcohols, cleared in xylene, and mounted with DePeX.
STATISTICAL ANALYSIS
Associations between clinicopathological variables and the frequency of genetic changes were assessed by 2 , Fisher's exact test, or the Wilcoxon rank sum statistic using a Statxact package. Probability (p) values of <0.05 were considered significant.
Results
PATHOLOGICAL FEATURES OF POLYPS FROM HNPCC SUBJECTS
The sites and pathological features of the 47 colorectal polyps are summarised in table 1. Seven of 14 adenomas (50%) measuring less than 5 mm, six of nine adenomas (66.7%) measuring 5-9 mm, and four of seven adenomas (57.1%) of >10 mm revealed high grade dysplasia. There was no correlation between adenoma size and grade of dysplasia (Wilcoxon rank sum statistic, p=0.619).
FREQUENCY OF MICROSATELLITE INSTABILITY
Informative PCR products were obtained from 60% of the nine microsatellite markers and bandshifts at four loci are shown for an MSI-H adenoma (fig 1) . Bandshifts occurred with similar frequencies in MSI-H adenomas regardless of marker type whereas dinucleotide markers were more sensitive for MSI-L adenomas (fig 2) . Two of 17 (11.8%) hyperplastic polyps showed MSI at one marker (D5S346). No hyperplastic polyp was classified as MSI-H. Twenty four (80%) of 30 adenomas revealed MSI. Eight of 24 (33.3%) adenomas were classified as MSI-L and 16 of 24 (66.7%) as MSI-H. Only one MSI-L adenoma showed bandshifts at more than one locus (three dinucleotide loci). Bandshifts were seen at 10/63 (16%) evaluable loci in MSI-L adenomas. In contrast, 67/93 (72%) evaluable loci in MSI-H adenomas showed bandshifts. Twelve mutations in coding regions were identified in nine adenomas from six HNPCC subjects. No coding region mutations were identified in hyperplastic polyps (table 2) .
MSI STATUS AND CLINICOPATHOLOGICAL
FEATURES OF HNPCC POLYPS
Adenomas displaying high grade dysplasia revealed MSI-H more frequently than those with low grade dysplasia (Fisher's exact test, p=0.004). There was no significant association between MSI status and sex, age, location, or size of adenomas. Nine of 14 (64.3%) adenomas less than 5 mm in size, four of nine (44.4%) of 5-9 mm, and three of seven (42.9%) more than 9 mm showed MSI-H (table 3) Mutations in repeat sequences of coding regions were detected in nine of 30 adenomas. One mutation was identified at TGF RII, two mutations at IGF2R and BAX, three mutations at hMSH3, and four mutations at hMSH6. Two adenomas showed mutations at two genes, one at IGF2R and hMSH6 and the second at hMSH3 and hMSH6. All nine adenomas with mutations in coding regions were MSI-H and eight (88.9%) showed high grade dysplasia. Three were only 2 or 3 mm in size and six of nine (66.7%) were less than 1 cm.
MSI-H status of adenomas was classified into three grades depending on the proportion of MSI positive markers among markers providing informative PCR products. Six adenomas showed MSI at 40-59% of markers, three at 60-79%, and seven at 80% or more. Four of four cases which showed mutations at hMSH6 revealed MSI at more than 80% of microsatellite markers (table 4) . There was a significant association between MSI involving 80% of loci or more and mutation of hMSH6 (p=0.02). In the present study, nine of 16 (56%) MSI-H adenomas were found to have mutations at one or more coding regions while none of 14 MSI-L or MSS cases showed coding region mutations. This fits with the low frequency of mononucleotide instability in MSI-L lesions (fig 2) as target coding sequences comprise mononucleotide runs. There was one (6.3%) mutation of TGF RII and two mutations of IGF2R (12.3%) and BAX (12.6%). Three (18.8%) and four (25.0%) of 16 MSI-H adenomas had mutations at hMSH3 and hMSH6, respectively. No adenoma had mutations at more than two coding regions. Compared with earlier studies 16 the frequency of mutation in coding regions, particularly in TGF RII, was low. These data suggest that mutations of TGF RII, IGF2R, and BAX follow no sequential pattern but cluster within adenomas showing MSI-H and high grade dysplasia (table 4) . Other genes, including CDX-2, 13 E2F-4, 14 caspase-5, 15 and as yet unknown genes may also be involved in adenoma progression.
Although HNPCC patients develop adenomas at about the same rate as the general population, HNPCC adenomas are more prone to malignant conversion than their sporadic counterparts. 4 Somatic mutations of additional mismatch repair genes may serve as secondary mutators and accelerate the accumulation of MSI and further coding region mutations. 21 Our data suggest that hMSH6 and hMSH3 may function as secondary mutators. The hMSH6 mutation occurred only in adenomas with the highest levels of MSI (table  4) . However, the possibility that mutation of MSH6 could be an epiphenomenon, secondary to the establishment of high levels of MSI-H, cannot be excluded. Furthermore, our data suggest that mutation of hMSH3 and hMSH6 cannot be the only explanation for the critical transition from MSI-L to MSI-H.
In spite of the right sided predominance of colon cancer in HNPCC and MSI positive sporadic colon cancers, 40 our data showed no significant association between location of adenoma and MSI (table 3) . Of nine adenomas with mutation of coding genes, only two were derived from the proximal colon. Jacoby and colleagues 20 and Akiyama and colleagues 16 also indicated no site predilection for HNPCC adenomas. The two hyperplastic polyps with MSI were obtained from the proximal colon. One hyperplastic polyp with MSI and TGF RII mutation has been reported. 7 The current data provide little evidence that sporadic hyperplastic polyps play a role in the
